Australian counterdrone solutions company DroneShield (ASX: DRO) has been awarded a two-year research and development contract worth $9.9 million by the Five Eyes Department of Defence (DoD). This substantial contract highlights DroneShield’s growing prominence in the defence industry and signifies the confidence placed in the Company’s capabilities by the Five Eyes intelligence alliance, comprising the
Read More
What’s in a brand name, when household income has been squeezed to its very last drop? Rising costs have compelled people to opt for generic meds instead of branded ones to save a few bucks wherever possible. And now, meds for chronic anal fissure pain are set to get a generic version, thanks to pharma
Read More
The XJO is expected to open flat this morning following a small gain in the U.S. overnight which showed their willingness to hold resistance going into their holiday. Their futures however have edged into the red, which may cause our market to follow suit in our morning session. Yesterday our market rallied stronger than expected
Read More
High energy costs have spared no one, neither customers nor companies. That’s why it has become integral to keep tabs on what’s emptying the corporate wallet and reign in the costs. To help with that, smart energy SaaS company Simble (ASX: SIS) is offering data analysis and carbon emission tracking platforms to help companies review
Read More
Diagnostic tech company Lumos Diagnostics (ASX: LDX) has received the green card from the US Food and Drug Administration (FDA) to market its FebriDx rapid, point-of-care test in the United States. This regulatory clearance permits the marketing of FebriDx in the US as an aid for healthcare professionals in diagnosing bacterial acute respiratory infections and
Read More
The XJO is expected to edge higher on open this morning following both a strong move higher in the U.S on Friday and their flat to positive futures this morning. This U.S had strong gains on Friday, but our market is only meekly translating this to roughly a thirty point gain this morning. This tests
Read More